Table 1.
Patient characteristics.
| Characteristics | n = 50 |
|---|---|
| Sex male, n (%) | 31 (64) |
| Age (years) | 69 ± 10 |
| HD duration (year) | 9.0 ± 8.8 |
| Primary disease, n (%) | |
| Diabetes mellitus | 17 (34) |
| Nephrosclerosis | 3 (6) |
| Chronic glomerulonephritis | 19 (38) |
| Others | 11 (22) |
| Past medical history, n (%) | |
| Hypertension | 44 (88) |
| Diabetes mellitus | 20 (40) |
| Bone fracture | 9 (18) |
| Ischemic heart disease | 8 (16) |
| Medication, n (%) | |
| Vitamin D | 34 (68) |
| P binder | 42 (84) |
| Calcimimetics | 11 (22) |
| Body mass index (kg/m2) | 22.1 ± 4.6 |
| Systolic BP (mmHg) | 150 ± 23 |
| Diastolic BP (mmHg) | 78 ± 12 |
| Heart rate (/min) | 69 ± 12 |
| Laboratory findings | |
| Albumin (g/dL) | 3.5 ± 0.4 |
| Serum sodium (mEq/L) | 138 ± 3 |
| Serum potassium (mEq/L) | 4.9 ± 0.7 |
| Serum calcium, mg/dL | 8.4 ± 0.6 |
| Serum phosphate (mg/dL) | 5.1 ± 1.1 |
| BUN (mg/dL) | 60 ± 13 |
| Cr (mg/dL) | 10.1 ± 1.1 |
| Hb (g/dL) | 11.2 ± 0.9 |
| Total cholesterol (mg/dL) | 156 ± 41 |
| Triglyceride (mg/dL) | 109 ± 68 |
| C-reactive protein (mg/dL) | 0.5 ± 0.9 |
| Intact PTH (pg/mL) | 154 ± 109 |
| ALP (U/L) | 245 ± 101 |
| BAP (μg/mL) | 16 ± 13 |
| TRACP-5b (mU/dL) | 491 ± 240 |
| ucOC (ng/mL) | 31 ± 15 |
| Total P1NP (ng/mL) | 257 ± 154 |
| Physical status and BMD | |
| Grip strength (kg) | 23 ± 8 |
| Skeletal muscle mass index (kg/m2) | 6.1 ± 1.2 |
| Lumbar spine bone density (g/cm2) | 0.91 ± 0.21 |
| Proxymal femur bone density (g/cm2) | 0.56 ± 0.12 |
HD, hemodialysis; BP, blood pressure; BUN, blood urea nitrogen; Cr, creatinine; Hb, hemoglobin; PTH, parathyroid hormone; ALP, alkaline phosphatase; BAP, bone specific alkaline phosphatase; TRACP-5b, tartrate-resistant acid phosphatase 5b; ucOC, undercarboxylated osteocalcin; P1NP, N-terminal propeptide of type I procollagen; BMD, bone mineral density.